Li Juan, Liu Jie, Li Pingping, Mao Xiaona, Li Wenjie, Yang Jin, Liu Peijun
Center for Translational Medicine, The First Affiliated Hospital, Xian Jiaotong University College of Medicine, 277 West Yanta Road, Xi'an, Shaanxi, 710061, People's Republic of China.
Department of Oncology, The First Affiliated Hospital, Xian Jiaotong University College of Medicine, 277 West Yanta Road, Xi'an, Shaanxi, 710061, People's Republic of China.
J Exp Clin Cancer Res. 2014 Sep 2;33(1):70. doi: 10.1186/s13046-014-0070-0.
LKB1, also known as STK11, is a master kinase that serves as an energy metabolic sensor and is involved in cell polarity regulation. Recent studies have indicated that LKB1 is related to breast tumorigenesis and breast cancer progression. However, little work has been done on the roles of LKB1 in cell polarity and epithelial-mesenchymal transition in breast cancer. In this study, we tried to prove that loss of LKB1 disrupts breast epithelial cell polarity and causes tumor metastasis and invasion.
The relationships of LKB1 expression to clinic-pathological parameters and epithelial markers E-cadherin and high-molecular-weight -cytokeratin (HMW-CK) were investigated in 80 clinical breast cancer tissue samples and their paired normal control breast tissue samples by using immunohistochemistry. Then, the LKB1 expressions in metastatic and non-metastatic breast cancer cell lines were compared. The roles of LKB1 in cell polarity and epithelial-mesenchymal transition in breast cancer were determined by using immunofluorescence, western blot assay, and cell migration and invasive assays. Finally, the non-transformed human breast cell line MCF-10A was cultured in three dimensions to further reveal the role of LKB1 in breast epithelial cell polarity maintenance.
Histopathological analysis showed that LKB1 expression level was significantly negatively correlated with breast cancer TNM stage, and positively correlated with ER/PR status and expression levels of E-cadherin and HMW-CK. Immunofluorescence staining showed that LKB1 was co-localized with E-cadherin at adheren junctions. In vitro analysis revealed that loss of LKB1 expression enhanced migration, invasion and the acquisition of mesenchymal phenotype, while LKB1 overexpression in MDA-MB-435 s cells, which have a low basal level of LKB1 expression, promoted the acquisition of epithelial phenotype. Finally, it was found for the first time that endogenous LKB1 knockdown resulted in abnormal cell polarity in acini formed by non-transformed breast epithelial cells grown in 3D culture.
Our data indicated that low expression of LKB1 was significantly associated with established markers of unfavorable breast cancer prognosis, such as loss of ER/PR, E-cadherin and HMW-CK. Knockdown of endogenous LKB1 gave rise to dysregulation of cell polarity and invasive phenotype of breast cancer cells.
LKB1,也被称为STK11,是一种主要激酶,作为能量代谢传感器,参与细胞极性调节。最近的研究表明,LKB1与乳腺肿瘤发生和乳腺癌进展有关。然而,关于LKB1在乳腺癌细胞极性和上皮-间质转化中的作用,相关研究较少。在本研究中,我们试图证明LKB1的缺失会破坏乳腺上皮细胞极性,并导致肿瘤转移和侵袭。
采用免疫组织化学方法,在80例临床乳腺癌组织样本及其配对的正常对照乳腺组织样本中,研究LKB1表达与临床病理参数以及上皮标志物E-钙黏蛋白和高分子量细胞角蛋白(HMW-CK)之间的关系。然后,比较转移性和非转移性乳腺癌细胞系中LKB1的表达情况。通过免疫荧光、蛋白质免疫印迹分析以及细胞迁移和侵袭实验,确定LKB1在乳腺癌细胞极性和上皮-间质转化中的作用。最后,将未转化的人乳腺细胞系MCF-10A进行三维培养,以进一步揭示LKB1在维持乳腺上皮细胞极性中的作用。
组织病理学分析表明,LKB1表达水平与乳腺癌TNM分期显著负相关,与ER/PR状态以及E-钙黏蛋白和HMW-CK的表达水平正相关。免疫荧光染色显示,LKB1与E-钙黏蛋白在黏附连接处共定位。体外分析表明,LKB1表达缺失增强了细胞迁移、侵袭以及间质表型的获得,而在LKB1基础表达水平较低的MDA-MB-435 s细胞中过表达LKB1,则促进了上皮表型的获得。最后,首次发现内源性LKB1敲低导致三维培养的未转化乳腺上皮细胞形成的腺泡中细胞极性异常。
我们的数据表明,LKB1低表达与不良乳腺癌预后的既定标志物显著相关,如ER/PR、E-钙黏蛋白和HMW-CK的缺失。内源性LKB1敲低导致乳腺癌细胞极性失调和侵袭表型。